glp 1 agonist liraglutide activates key brain circuits to trigger weight loss in obesity GLP-1s for Weight Loss: What

Basic research in PCOS: Are we reaching new frontiers

This underscores the need for both RWE and RCTs in parallel and reinforces the need to need to run clinical trials that reflect real-world populations, a topic explored in more detail in our blog Obesity trials on trial Some health improvement seen with GLP-1 therapy may be a direct effect of weight loss, rather than unique drug effect as seen by improvements in liver and kidney health 4

After its discovery in 1921, its contribution to the pathophysiology of type 2 diabetes mellitus opened a new age in antidiabetic medications and in the study of metabolic diseases

Emmerich SD, Fryar CD, Stierman B, Ogden CL, Obesity